1995
DOI: 10.1177/019262339502300404
|View full text |Cite
|
Sign up to set email alerts
|

Olfactory Toxicity of Methimazole: Dose-Response and Structure-Activity Studies and Characterization of Flavin-Containing Monooxygenase Activity in the Long-Evans Rat Olfactory Mucosa

Abstract: Methimazole is a compound administered to humans for the treatment of hyperthyroidism and is used experimentally as a model substrate for the flavin-containing monooxygenase (FMO) system. Previous results from this laboratory demonstrated that methimazole is an olfactory system toxicant, causing nearly complete destruction of the olfactory epithelium in the male Long-Evans rat following a single ip dose of 300 mg/kg.The present studies were undertaken to determine the dose-response relationship for methimazole… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
83
2
1

Year Published

1998
1998
2017
2017

Publication Types

Select...
5
3
1

Relationship

2
7

Authors

Journals

citations
Cited by 99 publications
(89 citation statements)
references
References 28 publications
3
83
2
1
Order By: Relevance
“…However, the specific P450 enzymes responsible for microsomal MMZ metabolism in either liver or OM have not been identified. In that connection, FMO1 and FMO2, as well as many P450s, are known to be expressed in the OM (Genter et al, 1995;Shehin-Johnson et al, 1995;Ling et al, 2004). Further studies are needed to determine the contributions of these FMOs and P450 enzymes (other than CYP2A5) to MMZ toxicity in the OM.…”
Section: Downloaded Frommentioning
confidence: 99%
See 1 more Smart Citation
“…However, the specific P450 enzymes responsible for microsomal MMZ metabolism in either liver or OM have not been identified. In that connection, FMO1 and FMO2, as well as many P450s, are known to be expressed in the OM (Genter et al, 1995;Shehin-Johnson et al, 1995;Ling et al, 2004). Further studies are needed to determine the contributions of these FMOs and P450 enzymes (other than CYP2A5) to MMZ toxicity in the OM.…”
Section: Downloaded Frommentioning
confidence: 99%
“…Methimazole (1-methyl-2-mercaptoimidazole; Tapazole) (MMZ), a drug commonly used for treating hyperthyroidism, and also often used as a model substrate, as well as an inhibitor, for the flavin-containing monooxygenases (FMO), is known to cause tissue-selective toxicity in rodent olfactory mucosa (OM) (Brittebo, 1995;Genter et al, 1995;Bergman and Brittebo, 1999;Bergström et al, 2003;Casallo Blanco et al, 2007). MMZ-induced olfactory deficits have also been reported in human patients (Bandyopadhyay et al, 2002;Woeber, 2002).…”
Section: Introductionmentioning
confidence: 99%
“…The methimazole-induced olfactory lesion model (25) has been widely used to study neuroregeneration in the OE. The death of OSNs in this model is considered to occur secondary to the degeneration of Bowman's glands and sustentacular cells.…”
Section: Olfactory Neuroregeneration Is Accompanied By An Acute Inflamentioning
confidence: 99%
“…Also carbimazole, a precursor of methimazole, may induce hyposmia (loss of sense of smell) in humans (9,27). Both of these drugs are olfactory toxicants in rodents (4,6,(12)(13)(14). For instance, in mice given a single IP injection of methimazole (50 mg/kg) there is necrosis throughout the olfactory region 1 day later, whereas the nasal respiratory mucosa and the liver are spared (6).…”
Section: Introductionmentioning
confidence: 99%